#RNA Analysis/Transcriptomics Market

[healthlogic]

RNA Analysis/Transcriptomics Market Partnering Deals of Key Players 2024 – 2031

The Insight Partners market research RNA Analysis/Transcriptomics Market Size and Share Report | 2031 is now available for purchase. This report offers an exclusive evaluation of a range of business environment factors impacting market participants. The market information included in this report is assimilated and reliant on a few strategies, for example, PESTLE, Porter's Five, SWOT examination, and market dynamics

RNA Analysis/Transcriptomics market is evaluated based on current scenarios and future projections are added keeping the projected period in consideration. This report integrates the valuation of RNA Analysis/Transcriptomics market size for esteem (million USD) and volume (K Units). Research analysts have used top-down, bottom-up, primary, and secondary research approaches to evaluate and approve the RNA Analysis/Transcriptomics market estimation.

Detailed scrutiny of market shares, optional sources, and basic essential sources has been done to integrate only valid facts. This research further reveals strategies to help companies grow in the RNA Analysis/Transcriptomics market.

Key objectives of this research are:

To contemporary market dynamics including drivers, challenges, threats, and opportunities in the RNA Analysis/Transcriptomics market.

To analyze the sum and market estimation of the worldwide RNA Analysis/Transcriptomics market

Based on key facets, market segments are added.

The competitive analysis covers key market players and their business strategies.

To examine the RNA Analysis/Transcriptomics Market for business probable and strategic outlook.

To review the RNA Analysis/Transcriptomics Market size, key regions and countries, end-users, and statistical details.

To offer strategic recommendations based on the latest market developments, and RNA Analysis/Transcriptomics market trends.

Perks of The Insight Partners’ RNA Analysis/Transcriptomics Market Research

Market Trends: Our report reveals developing RNA Analysis/Transcriptomics market trends that are poised to reshape the market preparing businesses with the foresight to retain their competitive edge. This Market research report presents market trends, supply chain analysis, leading participants, and business growth strategies. This research covers technological progress and key developments covering various aspects of the inclusive market. It is valuable market research for existing key players as well as new entrants in the RNA Analysis/Transcriptomics Market. Through inputs derived from experts, this research attempts to guide future investors about market details and potential returns on investment. 

Competitive Landscape: This research reveals key market players, their strategies, and possible areas for differentiation.

Analysts Viewpoint: We have industry-specific experts who add credibility to this report with their exclusive viewpoints based on market understanding and expertise. This report goes further into details of entire business processes and doesn’t restrict to only operational aspects. These insights cover venture economics and include tactics for capital investment, investor funding, and projections of ROIs.  Net income and profit loss financial stats are crucial metrics of this RNA Analysis/Transcriptomics market report. With these meticulous insights companies can reduce their risks and increase the success rate in the coming decade. 

RNA Analysis/Transcriptomics Market Report Coverage:

Report Attributes

Details

Segmental Coverage

Product

Consumables

Instruments

Software Services

Technology

Microarray

Real-Time Quantitative Polymerase Chain Reaction

Sequencing Technologies

Application

Diagnostics Disease Profiling

Drug Discovery Others

End User

North America

Europe

Asia Pacific

South Central America

and Geography

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

BioRad Laboratories Inc.

Illumina Inc.

GE Healthcare

F. HoffmannLa Roche Ltd.

Agilent Technologies Inc.

Thermofisher Scientific Inc.

Sigma Aldrich

Qiagen N.V.

Affymetrix Inc.

Fluidigm Corporation

Other key companies 

What all adds up to the credibility of this research?

A comprehensive summary of the contemporary RNA Analysis/Transcriptomics market scenario

Precise estimations on market revenue forecasts and CAGR to rationalize resources

Regional coverage to uncover new markets for business

Rivalry analysis aims to help corporations at a modest edge

Facts-based crystal-clear insights for business success

The research can be customized as per business necessities

Access to PDF, and PPT formats of this research

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us: www.theinsightpartners.com

[bisresearch0]

Spatiotemporal Omics Market: Growth Trends, Technologies, and Future Forecast

What is spatiotemporal omics?

Spatiotemporal omics is an advanced approach in molecular biology that integrates spatial and temporal dimensions into multi-omics analyses (e.g., genomics, transcriptomics, proteomics, metabolomics). This technique enables the mapping of biomolecular changes within the precise anatomical context of tissues over time, offering unprecedented resolution into how cellular behavior evolves in health and disease. It has transformative potential in areas such as oncology, neuroscience, immunology, and developmental biology, driving innovation in precision medicine and systems biology.

The Spatio OMICS Market is expected to grow at a significant rate due to advancements in sequencing and imaging technologies, and expansion of research and development funding.

Which technologies are driving the spatiotemporal omics market?

Spatial Transcriptomics – Maps gene expression in tissue context

Spatial Proteomics – Visualizes protein distribution

Mass Spectrometry Imaging (MSI) – Detects molecules with spatial precision

Single-Cell RNA Sequencing (scRNA-seq) – Captures temporal changes at cell level

Multiplexed Imaging (e.g., CODEX, MIBI) – Analyzes many biomarkers in tissues

What are the current limitations or challenges in spatiotemporal omics adoption?

High Technology Costs: The advanced instruments and reagents required for spatiotemporal omics are costly, making adoption challenging for many academic and smaller research institutions. This financial barrier limits access despite rising interest in spatial biology.

Complexity of Data Analysis: Spatiotemporal omics generate vast, high-dimensional datasets combining molecular and imaging data. Processing this information demands specialized software, computational infrastructure, and bioinformatics expertise. Without these, deriving actionable insights can be slow and resource-intensive.

Limited Skilled Workforce and Infrastructure: The field requires interdisciplinary skills in molecular biology, spatial imaging, and data science. However, a shortage of trained professionals and inadequate infrastructure in many regions slows down adoption and implementation across research and clinical environments.

To get detailed information on Spatiotemporal OMICS Industry, Click here!

Which regions are investing heavily in spatiotemporal omics research and development?

North America

Europe

Asia-Pacific

Latin America

Who are the leading players in the spatiotemporal omics industry?

10x Genomics

NanoString Technologies

Akoya Biosciences

Bruker Corporation

Vizgen

RareCyte

For a comprehensive analysis, refer to the full report by BIS Research: Spatiotemporal OMICS Market.

End Use Insights

Innovation Strategy: It identifies opportunities for market entry and technology adoption, helping organizations stay ahead of the competition while meeting evolving customer demands.

Growth Strategy: The report outlines targeted growth strategies to optimize market share, enhance brand presence, and drive revenue expansion.

Competitive Strategy: It evaluates key competitors and offers practical guidance for maintaining a competitive edge in a rapidly evolving market.

Conclusion

The market for spatiotemporal omics is expected to increase significantly due to growing applications in clinical and research settings, growing need for precision medicine, and technical advancements. To keep a competitive edge, major competitors in the market are always improving their product offerings, investing in R&D, and inventing. Despite obstacles like exorbitant expenses and intricate data, the amalgamation of artificial intelligence and multi-modal platforms offers significant prospects. Organizations that use these insights can take advantage of development opportunities, overcome obstacles, and set themselves up for long-term success in the ever-changing spatiotemporal omics landscape.

[aimarketresearch]

Tumor Transcriptomics Market Size, Share, Trends, Demand, Growth and Competitive Analysis

Executive Summary  Tumor Transcriptomics Market:

This international Tumor Transcriptomics Market business report includes strategic profiling of key players in the market, systematic analysis of their core competencies, and draws a competitive landscape for the market. It is the most appropriate, rational and admirable market research report provided with a devotion and comprehension of business needs. The report also estimates CAGR (compound annual growth rate) values along with its fluctuations for the definite forecast period. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the market has also been included in this market report. It all together leads to the company’s growth, by subsidizing the risk and improving the performance.

Competitive landscape in this report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and strategies. According to this Tumor Transcriptomics Market report, the global market is anticipated to witness a moderately higher growth rate during the forecast period. This Tumor Transcriptomics Market report is structured with the clear understanding of business goals of  industry and needs to bridge the gap by delivering the most appropriate and proper solutions. Businesses can confidently rely on the information mentioned in this Tumor Transcriptomics Market report as it is derived only from the important and genuine resources.

Discover the latest trends, growth opportunities, and strategic insights in our comprehensive Tumor Transcriptomics Market report. Download Full Report: https://www.databridgemarketresearch.com/reports/global-tumor-transcriptomics-market

Tumor Transcriptomics Market Overview

**Segments**

- **By Product Type**: The tumor transcriptomics market can be segmented into instruments, consumables, and services. Instruments include PCR machines, microarray equipment, and sequencing platforms. Consumables consist of reagents, RNA extraction kits, and assay kits. Services cover gene expression profiling, data analysis, and consulting services.

- **By Cancer Type**: This market segment is categorized into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. Each cancer type may require specific transcriptomic analysis for targeted therapies and personalized medicine.

- **By End-User**: The tumor transcriptomics market can be further divided into hospitals, cancer research centers, diagnostic laboratories, and pharmaceutical companies. Different end-users have varying needs for transcriptomic tools and services.

- **By Region**: Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each region has its own set of regulations, healthcare infrastructure, and adoption rates for tumor transcriptomics technology.

**Market Players**

- **Illumina, Inc.**: One of the key players in the tumor transcriptomics market, Illumina offers sequencing platforms and related services for cancer research and diagnostics.

- **Thermo Fisher Scientific Inc.**: This company provides a wide range of consumables and instruments for tumor transcriptomics analysis, catering to the needs of researchers and healthcare professionals.

- **Agilent Technologies**: Known for its microarray platforms and assay kits, Agilent Technologies is a major player in the global tumor transcriptomics market, offering solutions for gene expression profiling.

- **QIAGEN N.V.**: QIAGEN specializes in RNA extraction kits and bioinformatics tools essential for tumor transcriptomics, enabling researchers to analyze gene expression patterns in cancer.

- **Fluidigm Corporation**: With its innovative microfluidic technology, Fluidigm Corporation offers high-throughput solutions for single-cell analysis and gene expression studies in tumors.

The global tumor transcriptomics market is witnessing significant growth due to the rising prevalence of cancer worldwide and the increasing demand for precision medicine. Advancements in transcriptomic technologies, such as next-generation sequencing and microarray analysis, have enabled researchers to study gene expression patterns in tumors with high accuracy and throughput. Key market players are investing in product development, strategic collaborations, and expansion initiatives to capitalize on the growing opportunities in this market. As personalized medicine gains momentum, the use of tumor transcriptomics for patient stratification and treatment selection is expected to drive further market growth.

Market players such as Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, QIAGEN N.V., and Fluidigm Corporation are at the forefront of developing cutting-edge solutions for tumor transcriptomics. These companies offer a wide range of instruments, consumables, and services that cater to the diverse needs of hospitals, cancer research centers, diagnostic laboratories, and pharmaceutical companies. By focusing on product development and strategic collaborations, these key players are driving innovation in the market and expanding their global footprint.

In addition to technological advancements, the market is also influenced by regulatory landscapes and healthcare infrastructure in different regions. North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa each have unique market dynamics that shape the adoption and growth of tumor transcriptomics technology. Market players must navigate these regional differences to effectively penetrate local markets and capitalize on the growing demand for precision medicine solutions.

Advancements in transcriptomic technologies, such as next-generation sequencing, microarray analysis, and RNA extraction kits, have revolutionized the way researchers study gene expression patterns in tumors. This enhanced accuracy and throughput have paved the way for more precise cancer treatments, driving the demand for transcriptomic analysis tools and services across different cancer types. The shift towards personalized medicine, which relies heavily on tumor transcriptomics to identify specific gene expression patterns for tailored treatment decisions, is a key trend shaping the market dynamics.

Furthermore, while technological innovation remains a key driver of market growth, regional dynamics also play a crucial role in shaping the adoption and expansion of tumor transcriptomics technology. Different regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa have unique regulatory landscapes and healthcare infrastructures that impact market dynamics. Market players must navigate these regional differences effectively to tap into local markets and capitalize on the increasing demand for precision medicine solutions.

Looking ahead, the global tumor transcriptomics market is expected to maintain its upward trajectory as the emphasis on personalized medicine grows and the need for targeted therapies for different cancer types intensifies. Researchers and healthcare professionals are increasingly relying on transcriptomic analysis to gain a better understanding of cancer biology and develop innovative treatment strategies. Key market players will continue to drive innovation through strategic initiatives such as product launches, collaborations, and mergers, reinforcing their position in this competitive and rapidly evolving market landscape.

The Tumor Transcriptomics Market is highly fragmented, featuring intense competition among both global and regional players striving for market share. To explore how global trends are shaping the future of the top 10 companies in the keyword market.

Learn More Now: https://www.databridgemarketresearch.com/reports/global-tumor-transcriptomics-market/companies

DBMR Nucleus: Powering Insights, Strategy & Growth

DBMR Nucleus is a dynamic, AI-powered business intelligence platform designed to revolutionize the way organizations access and interpret market data. Developed by Data Bridge Market Research, Nucleus integrates cutting-edge analytics with intuitive dashboards to deliver real-time insights across industries. From tracking market trends and competitive landscapes to uncovering growth opportunities, the platform enables strategic decision-making backed by data-driven evidence. Whether you're a startup or an enterprise, DBMR Nucleus equips you with the tools to stay ahead of the curve and fuel long-term success.

Regional Analysis/Insights

The Tumor Transcriptomics Market is analyzed and market size insights and trends are provided by country, component, products, end use and application as referenced above.

The countries covered in the Tumor Transcriptomics Market reportare U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominatesthe Tumor Transcriptomics Market because of the region's high prevalence Tumor Transcriptomics Market

Asia-Pacific is expectedto witness significant growth. Due to the focus of various established market players to expand their presence and the rising number of surgeries in this particular region.

Browse More Reports:

Global Respiratory Syncytial Virus Treatment Market Global Resorcinol Market Global Refrigerated Vending Machine Market Global Recliner Sofas Market Global Railway Operation Management Market Global Radio Frequency (RF) Components Market Global Rabies Diagnostics Market Global PVC Additives Market Global Puerperal Sepsis Treatment Market Global Pregnancy Pillow Market Global Power Inductor Market Global Powdered Seaweed Market Global Potassium carbonate Market Global Portable Fabric Canopies Market Global Polyurethane Foam Market Global Polysulfide Market Global Polyoxymethylene (POM) Market Global Polyolefin Market Global Polyethylene Terephthalate (PET) Stretch Blow Molding Machines Market Global Polyethylene (PE) Foam Film Market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email:- corporatesales@databridgemarketresearch.com

Tag

Tumor Transcriptomics Market Size, Tumor Transcriptomics Market Share, Tumor Transcriptomics Market Trend, Tumor Transcriptomics Market Analysis, Tumor Transcriptomics Market Report, Tumor Transcriptomics Market Growth,  Latest Developments in Tumor Transcriptomics Market, Tumor Transcriptomics Market Industry Analysis, Tumor Transcriptomics Market Key Player, Tumor Transcriptomics Market Demand Analysis

[navyasri1]

RNA Analysis/Transcriptomics Market - Forecast(2024 - 2030)

Transcriptomics/RNA analysis can be defined as the study of the transcriptome or the complete set of RNA transcripts which are produced by the genome, under specific circumstances, environment or in a specific cell - using high-throughput methods, such as microarray analysis. Globally increasing R&D activities in RNA sequencing and trascriptomics is expected to remain key growth driver for the RNA analysis market during the period of study.

[harshnews]

Plant Genomics Market Size, Share, Trends, Growth Opportunities and Competitive Outlook

"Global Plant Genomics Market - Industry Trends and Forecast to 2029

Global Plant Genomics Market, By Type (Molecular Engineering, Genetic Engineering and Genome Editing and Others), Trait (Yield Improvement, Disease Resistance, Herbicide Tolerance and Others), Objective (DNA Extraction & Purification, DNA/RNA Sequencing, Genotyping, Gene Expression Profiling, Marker-Assisted Selection, GMO-trait Purity Testing, Hybrid Purity Testing, Targeted Resequencing, DNA Parentage Testing, QTL Mapping,  and Genetic Disease), Application (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Sugar Crops, Ornamentals and Alfalfa), Country (U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Access Full 350 Pages PDF Report @

**Segments**

- On the basis of application, the plant genomics market is segmented into transcriptomics, proteomics, metabolomics, and others. Transcriptomics involves the study of RNA molecules to understand gene expression levels, while proteomics focuses on studying proteins to unravel their functions. Metabolomics analyzes the metabolites within a cell or organism to gain insights into metabolic pathways and biochemical processes.

- In terms of technique, the market can be categorized into molecular markers, DNA sequencing, gene expression analysis, and other techniques. Molecular markers such as SSRs (Simple Sequence Repeats) and SNPs (Single Nucleotide Polymorphisms) are crucial for genetic mapping and marker-assisted breeding. DNA sequencing plays a fundamental role in deciphering plant genomes, while gene expression analysis helps in understanding how genes are regulated and activated.

- Based on end-users, the plant genomics market is segmented into academic research institutes, biotechnology companies, pharmaceutical companies, and others. Academic research institutes are at the forefront of exploring new frontiers in plant genomics, while biotechnology and pharmaceutical companies leverage genomics data for developing genetically modified crops, novel therapeutics, and plant-based products.

**Market Players**

- Some prominent players in the plant genomics market include Illumina Inc., Thermo Fisher Scientific Inc., Eurofins Scientific, Qiagen, Agilent Technologies, Biomatters Ltd., KeyGene, Danaher, LC Sciences, and PerkinElmer. These companies are heavily invested in developing cutting-edge genomics technologies, such as next-generation sequencing platforms, bioinformatics tools, and molecular markers for precision breeding programs. Illumina, in particular, is known for its high-throughput sequencing systems that have revolutionized genomics research across various sectors.

- Additionally, academic research institutions like the Boyce Thompson Institute, Max Planck Institute for Plant Breeding Research, and John Innes Centre play a significant role in advancing plant genomics through collaborative research, knowledge sharing, and technology transfer. ThesePlant genomics market is experiencing significant growth due to the increasing demand for sustainable agriculture practices, rising food security concerns, and advancements in genomic technologies. The application segment of the market plays a crucial role in understanding the complexities of plant biology. Transcriptomics, proteomics, and metabolomics provide valuable insights into gene expression, protein functions, and metabolic pathways, respectively, enabling researchers to develop crop varieties with desirable traits such as higher yield, stress resistance, and nutritional content. As the understanding of plant genomes deepens, the potential for targeted genetic modifications and precision breeding increases, driving the growth of the plant genomics market.

Technological advancements have propelled the plant genomics market forward, with molecular markers, DNA sequencing, and gene expression analysis being key techniques for studying plant genomes. Molecular markers like SSRs and SNPs are essential for genetic mapping and marker-assisted breeding programs, leading to the development of improved crop varieties with increased productivity and resilience to biotic and abiotic stresses. DNA sequencing has revolutionized the field of genomics by enabling the rapid and cost-effective decoding of plant genomes, facilitating genome-wide association studies and comparative genomics analyses. Gene expression analysis complements sequencing data by providing insights into how genes are regulated and function under different environmental conditions, offering valuable information for crop improvement strategies and trait selection.

The plant genomics market is driven by a diverse set of end-users, including academic research institutes, biotechnology companies, and pharmaceutical companies. Academic institutions play a crucial role in fundamental research and discovery, pushing the boundaries of plant genomics through collaboration and knowledge sharing. Biotechnology and pharmaceutical companies leverage genomics data to develop genetically modified crops, biopharmaceuticals, and plant-based products with enhanced traits and functionalities. These industry players drive innovation in plant genomics by translating research findings into practical applications that address global challenges such as food insecurity, climate change, and sustainable agriculture practices.

Prominent market players such as Illumina Inc., Thermo Fisher Scientific Inc., and Qiagen are at the**Segments:** - Molecular Engineering - Genetic Engineering and Genome Editing - Others

**Trait:** - Yield Improvement - Disease Resistance - Herbicide Tolerance - Others

**Objective:** - DNA Extraction & Purification - DNA/RNA Sequencing - Genotyping - Gene Expression Profiling - Marker-Assisted Selection - GMO-trait Purity Testing - Hybrid Purity Testing - Targeted Resequencing - DNA Parentage Testing - QTL Mapping - Genetic Disease

**Application:** - Cereals & Grains - Oilseeds & Pulses - Fruits & Vegetables - Sugar Crops - Ornamentals - Alfalfa

Global Plant Genomics Market is witnessing remarkable growth driven by advancements in genomic technologies and the increasing demand for sustainable agriculture solutions. The market segments based on molecular engineering, genetic engineering, and genome editing are pivotal in shaping the future of plant genomics research and application. Traits like yield improvement, disease resistance, and herbicide tolerance are key focus areas for developing genetically modified crops with enhanced characteristics. Objectives such as DNA extraction, genotyping, and gene expression profiling are instrumental in unraveling the genetic makeup of plants for targeted breeding and trait selection, contributing to agricultural innovation and productivity.

The application of plant genomics spans across various crops such as cereals, oilseeds, fruits, and vegetables, addressing specific needs in different agricultural sectors. The global market analysis

Major Points Covered in TOC:

Plant Genomics Market Overview: It incorporates six sections, research scope, significant makers covered, market fragments by type, Plant Genomics Market portions by application, study goals, and years considered.

Plant Genomics Market Landscape: Here, the opposition in the Worldwide Plant Genomics Market is dissected, by value, income, deals, and piece of the pie by organization, market rate, cutthroat circumstances Landscape, and most recent patterns, consolidation, development, obtaining, and portions of the overall industry of top organizations.

Plant Genomics Profiles of Manufacturers: Here, driving players of the worldwide Plant Genomics Market are considered dependent on deals region, key items, net edge, income, cost, and creation.

Plant Genomics Market Status and Outlook by Region: In this segment, the report examines about net edge, deals, income, creation, portion of the overall industry, CAGR, and market size by locale. Here, the worldwide Plant Genomics Market is profoundly examined based on areas and nations like North America, Europe, China, India, Japan, and the MEA.

Plant Genomics Application or End User: This segment of the exploration study shows how extraordinary end-client/application sections add to the worldwide Plant Genomics Market.

Plant Genomics Market Forecast: Production Side: In this piece of the report, the creators have zeroed in on creation and creation esteem conjecture, key makers gauge, and creation and creation esteem estimate by type.

Keyword: Research Findings and Conclusion: This is one of the last segments of the report where the discoveries of the investigators and the finish of the exploration study are given.

Browse Trending Reports:

Forage Harvester Market Calcify Uremic Arteriolopathy Drug Market Alexipharmic Drugs Market Resectoscope Market Coal To Liquid Market Air Electrode Battery Market Power Sports Batteries Market Body Scrub Market Cataplexy Treatment Market Alveolar Capillary Dysplasia Treatment Market Quantum Computing Market Control Valves Market Hemodialysis Peritoneal Dialysis Market Breathable Films Market Utility Locator Market Food Humectants Market Electronic Safety System Market Reporter Gene Assay Market Security Assertion Markup Language Saml Authentication Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[healthcaremarketanalysis]

RNA Analysis Industry worth $9.9 billion by 2028, with a CAGR of 13.4%

The global RNA analysis market growth forecasted to transform from USD 5.3 billion in 2023 to USD 9.9 billion by 2028, driven by a CAGR of 13.4%. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many peptide-based research projects are also being fostered by increasing collaborative partnerships among various companies that are driving market growth.

Download an Illustrative overview:

Browse in-depth TOC on "RNA Analysis Market"

178 - Tables

46 - Figures

263 - Pages

The reagents/consumables segment accounted for the largest share of the product & service segment in the RNA analysis market in 2022.

Based on product & service, the RNA analysis market is segmented into reagents/consumables, instruments, software, and services. In 2022, the reagents/consumables segment accounted for the largest share of the RNA analysis market. The large share of this segment is fueled by the increasing demand for omics-based therapeutics, expanding research and development activities, and the availability of various RNA analysis reagents in the market.

The PCR segment accounted for the largest share of the technology segment in the RNA analysis market in 2022.

Based on technology, the RNA analysis market is segmented into PCR, sequencing, microarrays, and RNA interference. The PCR segment accounted for the largest share in the RNA analysis market in 2022. PCR is associated with several advantages, such as ease of operation, and short production cycles. These advantages support the growth of the PCR in the RNA analysis segment.

Asia Pacific is likely to grow at the highest growth rate during the forecast period.

Based on the region The global RNA analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the RNA analysis market during the forecast period. The growth of the pharmaceuticals market in the region is primarily driven by the increasing prevalence of chronic diseases, the rising disposable incomes, the growing focus on personalized medicine, and the increasing government support for genomics and proteomics.

Request Sample Pages:

RNA Analysis Market Dynamics:

Drivers:

Growing demand for personalized medicine

Restraints:

High capital investments

Opportunities:

Opportunities in Emerging Countries

Challenges:

Data management in transcriptomics research

Key Market Players:

The prominent players operating in the RNA analysis market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), and Eurofins Scientific (Luxembourg).

Recent Developments:

In October 2022, Agilent Technologies and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.

In March 2022, Eurofins acquired Beacon Discovery, a drug discovery-based CRO. Beacon supported the fully integrated drug discovery programs from target validation to pre-clinical candidates.

In January 2021, Thermo Fisher acquired Phitonex to provide greater flow cytometry and imaging multiplexing capabilities for protein and cell analysis research needs. Phitonex's product offerings are also an expansion of the company's existing protein and cell analysis portfolio.

Get 10% Free Customization on this Report:

RNA Analysis Market Advantages:

Unraveling Gene Expression: RNA analysis allows researchers to study the dynamic gene expression patterns in cells and tissues, providing valuable insights into how genes are regulated and how they respond to different stimuli, disease conditions, or treatments.

Disease Understanding: By analyzing RNA profiles, scientists can gain a deeper understanding of the molecular basis of various diseases, including cancer, neurological disorders, and infectious diseases. This knowledge can lead to the identification of biomarkers and potential therapeutic targets.

Personalized Medicine: RNA analysis has the potential to enable personalized medicine approaches. By profiling an individual's RNA, clinicians can tailor treatments to the patient's specific genetic makeup and disease characteristics, increasing treatment efficacy and minimizing adverse effects.

Advancements in Therapeutics: RNA analysis plays a crucial role in the development of novel RNA-based therapeutics, such as RNA interference (RNAi) and mRNA vaccines. These groundbreaking treatments have the potential to target specific genes and revolutionize disease management.

Diagnostic Applications: RNA analysis offers a wide range of diagnostic applications. From detecting infectious agents to identifying specific genetic mutations associated with diseases, RNA-based diagnostic tests can provide faster, more accurate results than traditional methods.

Biotechnology and Drug Development: In the biotechnology and pharmaceutical industries, RNA analysis is utilized to assess the safety and efficacy of potential drugs. It helps identify potential drug targets and provides valuable information during preclinical and clinical trials.

Agricultural Advancements: RNA analysis is also applied in agriculture to improve crop yields, develop disease-resistant varieties, and enhance the nutritional content of food.

Non-Invasive Testing: In certain cases, RNA analysis can be performed on non-invasive samples such as blood, urine, or saliva, reducing the need for invasive procedures and making it easier to monitor patients over time.

Technological Advancements: The RNA analysis market is continuously evolving with advancements in sequencing technologies, bioinformatics, and automation. These innovations have led to increased throughput, reduced costs, and improved accuracy in data analysis.

Research Tools: The availability of diverse RNA analysis tools and kits allows researchers to perform experiments efficiently and cost-effectively, fostering a broader adoption of RNA-focused studies across academic and commercial laboratories.

Overall, the growing advantages of RNA analysis have positioned it as a pivotal component in advancing our understanding of biology, driving medical breakthroughs, and shaping the future of personalized medicine and precision healthcare.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

[shubhampawrainfinium]

A New Dimension of Biology: The Rise of Single Cell Multiomics

The global single cell multiomics market is experiencing significant growth, driven by advancements in biotechnology and the rising demand for precision medicine. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of approximately 18% during the forecast period of 2022-2028. In 2022, the global single cell multiomics market was valued at around USD 3.5 billion, and it is expected to reach nearly USD 9.5 billion by 2028.

What is Single Cell Multiomics?

Single cell multiomics is an advanced analytical approach that studies individual cells by combining multiple 'omics' platforms, such as genomics, transcriptomics, proteomics, and epigenomics. This method provides a comprehensive understanding of the cellular functions and the underlying molecular mechanisms. By analyzing a single cell's DNA, RNA, proteins, and epigenetic markers, researchers can uncover unique insights into cellular heterogeneity and disease mechanisms that are not possible with bulk cell analysis.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/35323

Market Dynamics and Growth Drivers

Several factors are contributing to the rapid growth of the global single cell multiomics market:

Rising Demand for Precision Medicine: Precision medicine aims to tailor medical treatments to individual patients based on their genetic and molecular profile. Single cell multiomics plays a pivotal role in this approach by providing detailed insights into individual cells, enabling better understanding and treatment of complex diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.

Technological Advancements: Advances in next-generation sequencing (NGS), mass spectrometry, and bioinformatics have made it easier and more cost-effective to conduct single cell multiomics studies. These innovations are driving adoption across academic and clinical research settings, allowing for more comprehensive analysis of cellular functions.

Growing Focus on Cancer Research: Cancer research is one of the primary applications of single cell multiomics, as it helps to decipher tumor heterogeneity, drug resistance, and tumor microenvironments at the single-cell level. The growing prevalence of cancer globally is fueling the demand for single cell multiomics in oncology research.

Increased Government and Private Funding: Governments and private organizations are investing heavily in genomics and precision medicine initiatives, providing funding and grants to support research in single cell analysis. These efforts are expected to boost market growth during the forecast period.

Regional Analysis

North America: North America holds the largest share of the global single cell multiomics market, primarily driven by the region’s advanced healthcare infrastructure, significant investment in precision medicine, and the presence of key market players. The United States, in particular, is a hub for genomics research, with major academic and research institutions adopting single cell technologies.

Europe: Europe is another prominent market for single cell multiomics, with countries like the U.K., Germany, and France at the forefront of multiomics research. The region’s robust research landscape, coupled with government initiatives supporting genomics research, is contributing to market growth.

Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing investments in biotechnology and healthcare research in countries like China, Japan, and India. Growing awareness about precision medicine and improving healthcare infrastructure are also key factors driving market expansion in this region.

Rest of the World: While the adoption of single cell multiomics is still in its early stages in regions like Latin America and the Middle East & Africa, growing interest in genomics and personalized medicine is expected to create future growth opportunities.

Competitive Landscape

The global single cell multiomics market is highly competitive, with several key players actively contributing to advancements in the field. Major companies include:

10x Genomics: A leader in single cell sequencing technologies, offering solutions that enable comprehensive single cell multiomics analysis for research and clinical applications.

Illumina, Inc.: A major player in the genomics space, providing sequencing platforms and technologies that support single cell analysis and multiomics studies.

Fluidigm Corporation: Specializes in developing single cell proteomics and genomics platforms, helping researchers investigate cellular heterogeneity and molecular interactions.

Becton, Dickinson and Company (BD): Offers innovative solutions for single cell multiomics, including platforms for high-dimensional proteomics and transcriptomics.

QIAGEN: Known for its sample preparation and bioinformatics solutions, QIAGEN supports multiomics research by enabling comprehensive data analysis and integration.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-single-cell-multiomics-market

Challenges and Opportunities

Despite its promising growth, the single cell multiomics market faces several challenges. High costs associated with single cell technologies and data analysis, as well as the complexity of multiomics data interpretation, may hinder widespread adoption, particularly in resource-constrained regions. Additionally, the integration of multiple 'omics' datasets and the lack of standardized protocols pose technical challenges.

However, there are substantial opportunities for growth. Continuous advancements in technology, decreasing costs of sequencing, and the growing adoption of artificial intelligence (AI) and machine learning (ML) for data analysis are expected to drive market expansion. Furthermore, as researchers uncover more insights into cellular heterogeneity, new applications of single cell multiomics in disease research, drug development, and personalized medicine are likely to emerge.

Conclusion

The global single cell multiomics market is poised for robust growth, with a projected CAGR of nearly 18% from 2022 to 2028. This market's expansion is fueled by increasing demand for precision medicine, advancements in biotechnology, and growing research applications in cancer and drug development. As the field of single cell multiomics continues to evolve, it holds the potential to revolutionize healthcare by enabling more accurate diagnostics, personalized treatments, and a deeper understanding of complex diseases.

[credenceresearchdotblog]

The nucleic acid isolation and purification market is indeed poised for substantial growth, with an anticipated value of USD 10.10 billion by 2032, reflecting a notable compound annual growth rate (CAGR) of 9.11% from USD 4.22 billion in 2023.The nucleic acid isolation and purification market is experiencing substantial growth, driven by advancements in biotechnology and increased research investments. This market encompasses a range of technologies and methodologies designed to extract and purify nucleic acids—DNA and RNA—from biological samples, which are essential for various applications in research, diagnostics, and therapeutics.

Browse the full report at https://www.credenceresearch.com/report/nucleic-acid-isolation-and-purification-market

Market Overview

Nucleic acid isolation and purification are critical processes in molecular biology, genomics, and personalized medicine. These processes enable scientists and researchers to study genetic material with high precision, paving the way for breakthroughs in disease understanding, drug development, and clinical diagnostics. The market for these technologies is expanding due to the growing demand for high-quality nucleic acid samples and the increasing prevalence of genetic disorders and cancer.

Market Drivers

1. Advancements in Biotechnology: The rapid progress in genomic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), has spurred demand for reliable and efficient nucleic acid isolation and purification methods. These advancements are crucial for obtaining high-quality samples needed for accurate genomic analysis.

2. Rising Prevalence of Genetic Disorders: With the increasing incidence of genetic disorders and cancer, there is a heightened demand for genetic testing and personalized medicine. Accurate nucleic acid extraction and purification are essential for reliable diagnostic results and tailored treatment strategies.

3. Growing Research and Development Activities: Continuous research in fields like genomics, transcriptomics, and epigenomics requires advanced nucleic acid isolation and purification techniques. The proliferation of research activities in these areas contributes to the market's growth.

4. Technological Innovations: The development of automated systems and high-throughput platforms has enhanced the efficiency and scalability of nucleic acid isolation and purification processes. Innovations such as magnetic bead-based purification and microfluidic devices are driving market expansion.

Market Segmentation

The nucleic acid isolation and purification market can be segmented based on technology, product type, application, and end-user:

1. By Technology: Key technologies include column-based methods, magnetic bead-based methods, and gel electrophoresis. Magnetic bead-based methods are gaining popularity due to their high sensitivity and automation capabilities.

2. By Product Type: This segment includes kits, reagents, and instruments. Kits, which offer convenience and comprehensive solutions, dominate the market. Reagents and instruments are also essential components, with continuous innovation driving their adoption.

3. By Application: The primary applications are in research and development, diagnostics, and therapeutics. Research and development hold the largest share, driven by the need for genomic and transcriptomic studies.

4. By End-User: End-users include academic and research institutions, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology companies. Academic and research institutions are significant contributors to the market due to their extensive research activities.

Regional Analysis

The nucleic acid isolation and purification market exhibits diverse trends across regions:

1. North America: The North American market is the largest, driven by the presence of major biotechnology firms, advanced research facilities, and significant investments in healthcare research.

2. Europe: Europe is also a major market, with a strong emphasis on research and development and a growing focus on personalized medicine. Countries like Germany and the UK are key contributors.

3. Asia-Pacific: The Asia-Pacific region is witnessing rapid growth due to increasing investments in research and development, expanding healthcare infrastructure, and a rising number of biotechnology firms. Countries like China and India are emerging as prominent players.

4. Latin America and the Middle East & Africa: These regions are experiencing steady growth, driven by improving healthcare infrastructure and increasing research activities.

Challenges and Future Outlook

Despite the market's growth, there are challenges such as high costs of advanced technologies and the need for skilled personnel. However, the ongoing development of cost-effective solutions and user-friendly platforms is expected to address these issues.

Looking ahead, the nucleic acid isolation and purification market is poised for continued growth, fueled by technological advancements, increasing research activities, and rising demand for genetic testing. The integration of artificial intelligence and machine learning in these processes is likely to further enhance efficiency and accuracy.

Key player:

QIAGEN N.V.

Thermo Fisher Scientific Inc.

Illumina Inc.

Danaher Corporation

Hoffmann La Roche Ltd

Merck KGaA

Agilent Technologies Inc.

Bio-Rad Laboratories

Takara Bio Inc.

Promega Corporation

New England Biolabs

Abcam plc.

PCR Biosystems

Segments:

By Product:

Kits

Reagents

Instruments

By Application:

Plasmid

DNA

RNA

By End User:

Pharmaceutical Companies

Biotechnology Companies

Contract Research Organizations

Academic Research Institutes

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/nucleic-acid-isolation-and-purification-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[creativeera]

Third Generation Sequencing Market is driven by personalized medicine

The third generation sequencing market allows for a rapid and affordable method of genome sequencing with single molecule technology. These sequencing platforms provide longer read lengths, higher accuracy, and can process DNA/RNA without relying on amplification. Third generation sequencing enables high throughput analysis of epigenetic patterns, DNA methylation, and direct RNA sequencing.

The Global Third Generation Sequencing Market is estimated to be valued at US$ 11.64 Mn in 2024 and is expected to exhibit a CAGR of 4.6% over the forecast period 2024 To 2031. Key players operating in the third generation sequencing are Pfizer, Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Sanofi, Amgen Inc. These companies have extensive research and development capabilities and distribute diagnostic systems and sequencing reagents for clinical applications. The growing demand for personalized medicine is expected to drive the third generation sequencing market. Sequencing technologies that provide long reads at high throughput allow comprehensive analysis of genomes and transcriptomes. This enables tailored treatment strategies based on an individual's genetic profile. The ability to determine epigenetic patterns and gene expression levels precisely helps develop targeted therapies. Globally, increasing research activities in genomics and investments made by government and private organizations are expanding the applications of Third Generation Sequencing Market Demand. Several countries have launched national genome projects that apply long-read sequencing for genomic studies. Such initiatives are accumulating sequence data to advance precision medicine. Additionally, declining costs of sequencing are improving accessibility in emerging markets of Asia Pacific and Latin America. One of the key trends in the third generation sequencing market is the integration of nanopore sequencing in clinical diagnosis. Being portable and able to produce real-time sequencing signals, nanopore technologies are finding usage in point-of-care testing. Customized nanopore devices coupled with artificial intelligence can expedite detection of mutations from a single drop of blood. This paves way for affordable personalized care in remote locations.

Porter’s Analysis Threat of new entrants: new entrants face high capital requirements and established competitive dynamics. Bargaining power of buyers: Third Generation Sequencing Market Analysis large pharmaceutical companies have substantial bargaining power over suppliers. Bargaining power of suppliers: suppliers have moderate bargaining power given differentiated products and customers. Threat of new substitutes: threat is moderate as new technologies can disrupt the market. Competitive rivalry: market dominated by large incumbents seeking to expand product portfolios. Get more insights on Third Generation Sequencing Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[omkarpatel]

Spatial Genomics Transcriptomics is Estimated to Witness High Growth Owing to Opportunity of Healthcare Advancements

Spatial genomics transcriptomics is an emerging technique which allows simultaneous analysis of RNA expression levels within individual cells in their original tissue context at high resolution. It enables unbiased mapping of the cellular composition of tissues and detecting cell types, states and interactions in situ. The technique combines spatial imaging with sequencing to determine where transcripts are located in fixed and stained tissues. This provides immense advantages over other bulk tissue RNA-seq techniques as it offers spatial context and cellular resolution of gene expression.

The global Spatial Genomics Transcriptomics Market s estimated to be valued at US$ 450 million in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The key opportunity driving the high growth of the spatial genomics transcriptomics market is its potential to advance healthcare. Spatial genomics can unravel the complex interplay between cells in healthy and diseased tissues. This technique is being applied to further understand various disease conditions like cancer at an unprecedented scale and resolution. Researchers are mapping expression of genes in tissues to gain novel insights into development and progression of diseases. Spatial understanding of genetic changes in situ can prove pivotal in discovering biomarkers and designing more precise therapies. Several biopharma companies are investing heavily in spatial genomics to accelerate drug discovery and development efforts. The ability of this technique to provide precise spatial mapping of gene expression holds immense potential to transform healthcare in the coming years. Porter’s Analysis Threat of new entrants: The spatial genomics transcriptomics market requires high capital investment and established distribution channels which poses significant barriers for new players. Bargaining power of buyers: Large pharmaceutical companies have strong bargaining power due to their high volume purchases. However, various product options provide flexibility to buyers. Bargaining power of suppliers: Key technology providers like 10x Genomics have considerable influence over prices and innovations. Nonetheless, their dependence on a small buyer base mitigates bargaining power. Threat of new substitutes: Limited substitutes exist for spatial genomics transcriptomics techniques due to their unique capability to detect molecular profiles of tissues at high resolution. Competitive rivalry: Players like NanoString and Illumina compete intensely on technology advancements, licensing deals and geographic expansions. SWOT Analysis Strength: Spatial genomics transcriptomics provides comprehensive single-cell analysis without requiring cell dissociation. It allows mapping gene expression in anatomical context of tissues. Weakness: High costs, complex workflow and heavy data analysis requirements restrict wider adoption. Challenges remain in achieving optimal resolution, scale and specificity. Opportunity: Growing R&D in genomics, drug discovery and development is stimulating demand. Potential clinical applications include cancer diagnostics, neuroscience and inflammatory diseases. Threats: Stringent regulatory norms and data privacy laws pose compliance issues. Slow commercialization compared to other omics technologies. Key Takeaways The global spatial genomics transcriptomics market is expected to witness high growth. Advancing capabilities to reveal cell-type organization and gene correlations at microanatomical scales will support market rise. The global Spatial Genomics Transcriptomics Market is estimated to be valued at US$ 300 million in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023-2030. North America dominates current demand owing to extensive research and technology development activities in the region. Asia Pacific is likely to be the fastest growing market for spatial genomics transcriptomics during the forecast period. Countries like China, India and South Korea are strengthening genomic research infrastructure which will support technology adoption. Key players: Key players operating in the spatial genomics transcriptomics market are 10x Genomics, NanoString Technologies, Seven Bridges Genomics, Dovetail Genomics, S2 Genomics and others. 10x Genomics has established itself as the market leader by launching product upgrades frequently and filing patents for new techniques.

[delvenservices]

RNA-Sequencing & Analysis Market Industry Share & Growth Leaders

RNA-Sequencing & Analysis (RNA-seq) Market, By Product and Services (RNA Sequencing Platforms and Consumables, Sample Preparation Products, RNA Sequencing Services, Data Analysis, Storage and Management),Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), End User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

The Global RNA-Sequencing & Analysis (RNA-seq) Market size was estimated at USD 2.8 billion in 2022 and is projected to reach USD 8.7 billion in 2030 at a CAGR of 17.7% during the forecast period 2023-2030.

RNA-seq is a widely used technique that provides comprehensive insights into the genomic makeup of an organism or cell. This technique is used in both traditional and non-traditional applications, such as identifying gene expression patterns, detecting mutations, and studying epigenetic modifications. The demand for better sequencing-based diagnostics has led to the development of novel sequencing technologies that can provide more accurate and reliable results. High-throughput sequencers and portable units are two examples of such technologies that have become increasingly popular due to their ability to generate large amounts of data quickly and efficiently.

Next-generation sequencing (NGS) technology is a relatively new technology that has gained immense popularity since its launch due to its ability to provide advanced and comprehensive genetic insights. NGS technology is widely used in both traditional and non-traditional applications, such as in research, clinical diagnostics, and personalized medicine, to analyze DNA and RNA sequences. The growing demand for enhanced sequencing-based diagnostics has led to the development of new sequencing technologies that offer improved accuracy, speed, and cost-effectiveness.

 RNA sequencing is a technique used to determine the sequence of nucleotides in RNA molecules, which can provide valuable information about the virus's genetic makeup. Single-cell RNA sequencing, stranded RNA sequencing, and ultra-low input RNA sequencing are different methods used to study the virus's features and epidemiology across diverse countries. Single-cell RNA sequencing allows researchers to study individual cells and their gene expression patterns, while stranded RNA sequencing can determine the directionality of RNA molecules. Ultra-low input RNA sequencing is used when only a small amount of RNA is available for analysis.

Request Research Sample Pages: https://www.delvens.com/get-free-sample/rna-sequencing-and-analysis-market-trends-forecast-till-2030

Delvens Industry Expert's Standpoint

Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that has revolutionized the field of genomics. Paired-end (PE) sequencing is a type of NGS that allows for the simultaneous sequencing of both ends of DNA fragments in a library. This technique produces twice as many reads as single-end sequencing, which only sequences one end of the DNA fragment. The forward and reverse reads produced by PE sequencing are aligned as reading pairs, which improves the accuracy of read alignment and enables the detection of insertions and deletions (indels) in the DNA sequence. Indels are important genetic variations that can cause diseases or affect an individual's response to drugs. The ability to detect indels is not achievable with single-read data, which makes PE sequencing a more powerful tool for genomic research. The paired-end strategy is the most modern and well-liked technique among researchers because of its ability to produce high-quality sequencing data and detect genetic variations that are not detectable by other sequencing methods.

Key Findings

On the basis of product and services, these are the products that are used to prepare the RNA samples for sequencing. RNA samples need to be extracted from the cells or tissues and then purified before they can be sequenced. Sample preparation products include kits, reagents, and instruments that are used for RNA extraction, purification, and quality control. services that are offered by sequencing companies or core facilities. Sequencing services include sample processing, library preparation, sequencing, and data analysis. These services are useful for researchers who do not have access to sequencing instruments or who do not have the expertise to perform sequencing themselves. RNA sequencing generates large amounts of data that need to be processed, analyzed, and stored. Data analysis includes quality control, alignment, quantification, and differential expression analysis.  

On the basis of technology, Sequencing by Synthesis is a method of DNA sequencing that involves the use of fluorescently labeled nucleotides to identify the sequence of the DNA strand. This method is commonly used in next-generation sequencing (NGS) technologies. Ion Semiconductor Sequencing is a type of NGS technology that uses a semiconductor chip to detect changes in pH caused by the release of hydrogen ions during DNA synthesis. This method is known for its speed and low cost. Single-molecule Real-time Sequencing is another NGS technology that uses a process called zero-mode waveguides to observe the synthesis of DNA in real-time. This method is known for its ability to detect modifications to DNA, such as methylation. Nanopore Sequencing is a third type of NGS technology that uses a nanopore to detect changes in electrical current as DNA strands pass through the pore. This method is known for its ability to sequence long DNA fragments and detect modifications to DNA.  

On the basis of Application, Expression Profiling Analysis refers to the process of measuring the expression levels of genes in a given sample. This is done by sequencing the RNA molecules present in the sample and analyzing the resulting data to determine which genes are being transcribed and at what levels. Small RNA Sequencing is a specialized type of RNA sequencing that focuses on the small RNA molecules present in a sample. These molecules are typically less than 200 nucleotides in length and play important roles in gene regulation and other cellular processes. De Novo Transcriptome Assembly is the process of reconstructing the complete set of RNA transcripts present in a sample, without the need for a reference genome. This is done by assembling short RNA sequencing reads into longer contiguous sequences, which can then be annotated and analyzed.  

The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America dominating the NGS-based RNA-sequencing market due to the increasing initiatives and funds from the government for genomics research, growing occurrences of chronic diseases, adoption of RNA-Seq products.

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/rna-sequencing-and-analysis-market-trends-forecast-till-2030

Regional Analysis

North America to Dominate the Market

North America dominating the NGS-based RNA-sequencing market due to the increasing initiatives and funds from the government for genomics research.  

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increasing levels of investment for research activities and occurrence of better health facilities.

Competitive Landscape

Illumina Inc. (US)

Thermo Fischer Scientific Inc. (US)

Oxford Nanopore Technologies plc (UK)

Agilent Technologies, Inc. (US)

BGI (China)

PerkinElmer Inc. (US)

QIAGEN (Germany)

Eurofins Scientific (Luxembourg)

F. Hoffmann-La Roche Ltd (Switzerland)

Takara Bio Inc. (Japan)

GENEWIZ, Inc. (US)

Hamilton Company (US)

Macrogen Inc. (South Korea)

Zymo Research Corporation (US)

Tecan Trading AG (Switzerland)

Recent Developments

In July 2022, Illumina Inc launched Illumina DRAGEN v4.0, an accurate and comprehensive secondary analysis platform.  

In January 2021, Oxford Nanopore Technologies collaborated with NVIDIA to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high-throughput sequencing system, PromethION.

Purchase the Research Report: https://www.delvens.com/checkout/rna-sequencing-and-analysis-market-trends-forecast-till-2030

[john9028]

Spatial Genomics and Transcriptomics Market share,trends,application and demand analysis 2033

Spatial genomics and transcriptomics are innovative technologies that allow the visualization and analysis of gene expression patterns and their spatial distribution within tissues or even single cells. These techniques combine the power of traditional genomics and transcriptomics with high-resolution imaging to provide a comprehensive understanding of gene expression at a spatially resolved level. Spatial genomics aims to study the organization and function of the genome within the three-dimensional (3D) context of the cell or tissue. It allows researchers to map the location of genes, regulatory elements, and structural variations within the genome in situ, providing valuable information about the architecture and regulation of the genome. On the other hand, spatial transcriptomics is a technique that enables the spatial mapping of transcriptomes, which are the complete set of RNA transcripts produced by a cell or tissue. By preserving the spatial information of the transcriptome,.

Read More: https://wemarketresearch.com/reports/spatial-genomics-and-transcriptomics-market/29